265 related articles for article (PubMed ID: 2683782)
1. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
[TBL] [Abstract][Full Text] [Related]
2. Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies.
Prockop DJ; Colige A; Helminen H; Khillan JS; Pereira R; Vandenberg P
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S489-92. PubMed ID: 8122517
[TBL] [Abstract][Full Text] [Related]
3. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
Gajko-Galicka A
Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
[TBL] [Abstract][Full Text] [Related]
4. Molecular heterogeneity in osteogenesis imperfecta type I.
Willing MC; Pruchno CJ; Byers PH
Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of osteogenesis imperfecta and related disorders of bone.
Prockop DJ; Kuivaniemi H; Tromp G
Clin Plast Surg; 1994 Jul; 21(3):407-13. PubMed ID: 7924138
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
Wenstrup RJ; Lever LW; Phillips CL; Quarles LD
Am J Med Genet; 1993 Jan; 45(2):228-32. PubMed ID: 8456807
[TBL] [Abstract][Full Text] [Related]
7. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
Yang W; Battineni ML; Brodsky B
Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
[TBL] [Abstract][Full Text] [Related]
8. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene.
Cohen-Solal L; Zolezzi F; Pignatti PF; Mottes M
Mol Cell Probes; 1996 Jun; 10(3):219-25. PubMed ID: 8799376
[TBL] [Abstract][Full Text] [Related]
9. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
10. Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta.
Dyne K; Cetta G; Tenni R; Rossi A; Finardi E; Brunelli PC; Castellani AA
Ital J Biochem; 1987; 36(4):256-66. PubMed ID: 3429209
[TBL] [Abstract][Full Text] [Related]
11. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
Stacey A; Bateman J; Choi T; Mascara T; Cole W; Jaenisch R
Nature; 1988 Mar; 332(6160):131-6. PubMed ID: 2450280
[TBL] [Abstract][Full Text] [Related]
12. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
Bächinger HP; Morris NP; Davis JM
Am J Med Genet; 1993 Jan; 45(2):152-62. PubMed ID: 8456797
[TBL] [Abstract][Full Text] [Related]
13. Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta.
Constantinou-Deltas CD; Ladda RL; Prockop DJ
Am J Med Genet; 1993 Jan; 45(2):246-51. PubMed ID: 8456810
[TBL] [Abstract][Full Text] [Related]
14. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta.
Labhard ME; Wirtz MK; Pope FM; Nicholls AC; Hollister DW
Mol Biol Med; 1988 Dec; 5(3):197-207. PubMed ID: 3244312
[TBL] [Abstract][Full Text] [Related]
15. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
Constantinou CD; Nielsen KB; Prockop DJ
J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
[TBL] [Abstract][Full Text] [Related]
17. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
Radmer RJ; Klein TE
Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
[TBL] [Abstract][Full Text] [Related]
18. Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta.
Pace JM; Atkinson M; Willing MC; Wallis G; Byers PH
Hum Mutat; 2001 Oct; 18(4):319-26. PubMed ID: 11668615
[TBL] [Abstract][Full Text] [Related]
19. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum protein Hsp47 binds specifically to the N-terminal globular domain of the amino-propeptide of the procollagen I alpha 1 (I)-chain.
Hu G; Gura T; Sabsay B; Sauk J; Dixit SN; Veis A
J Cell Biochem; 1995 Nov; 59(3):350-67. PubMed ID: 8567753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
